Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Lubner David Charles Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2023 4 Lubner David Charles (Director) has filed a Form 4 on Arcellx, Inc.
Txns: Granted 11,459 options to buy @ $37.94, valued at $434.8k
06/05/2023 4 Lubner David Charles (Director) has filed a Form 4 on POINT Biopharma Global Inc.
Txns: Granted 44,749 options to buy @ $9.12, valued at $408.1k
06/02/2023 4 Lubner David Charles (Director) has filed a Form 4 on Vor Biopharma Inc.
Txns: Granted 30,000 options to buy @ $4.79, valued at $143.7k
05/25/2023 4 Lubner David Charles (Director) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Granted 24,900 options to buy @ $13.49, valued at $335.9k
11/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Lubner David Charles (Director) has filed a Form 4 on Vor Biopharma Inc.
Txns: Granted 16,911 options to buy @ $4.26, valued at $72k
06/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2021 4 Lubner David Charles (Director) has filed a Form 4 on Gemini Therapeutics, Inc. /DE
Txns: Granted 17,245 options to buy @ $3.8, valued at $65.5k
07/08/2021 4 Lubner David Charles (Director) has filed a Form 4 on POINT Biopharma Global Inc.
Txns: Granted 25,000 options to buy @ $8.47, valued at $211.8k
05/27/2021 4 Lubner David Charles (Director) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Granted 19,596 options to buy @ $19.56, valued at $383.3k
04/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/23/2020 4 Lubner David Charles (Director) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Converted 53,625 shares @ $0
Granted 11,156 options to buy @ $5.54, valued at $61.8k
Granted 14,444 options to buy @ $5.54, valued at $80k
Bought 177,872 preferred shares @ $2.811, valued at $500k
Converted 177,872 preferred shares @ $0
04/03/2020 4 Lubner David Charles (Executive VP and CFO) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Disposed/sold 15,622 shares @ $48, valued at $749.9k
Disposed/sold 115,572 options to buy @ $2.87, valued at $331.7k
Disposed/sold 92,283 options to buy @ $2.87, valued at $264.9k
Disposed/sold 28,571 options to buy @ $5.6, valued at $160k
Disposed/sold 112,500 options to buy @ $16.64, valued at $1.9M
Disposed/sold 62,500 options to buy @ $7.33, valued at $458.1k
Disposed/sold 133,000 options to buy @ $21, valued at $2.8M
Disposed/sold 10,416 restricted stock units @ $0
06/07/2019 4 Lubner David Charles (Director) has filed a Form 4 on Nightstar Therapeutics plc
Txns: Disposed/sold 29,124 shares @ $25.5, valued at $742.7k
Disposed/sold 18,200 options to buy @ $12.27, valued at $223.3k
Disposed/sold 21,000 options to buy @ $13.57, valued at $285k
02/05/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/29/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/05/2018 4 Lubner David Charles (Executive V.P. & CFO) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Granted 62,500 options to buy @ $7.33, valued at $458.1k
Granted 31,250 restricted stock units @ $0
02/03/2017 4 Lubner David Charles (Executive V.P. & CFO) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Granted 112,500 options to buy @ $16.64, valued at $1.9M
10/31/2016 4 Lubner David Charles (EVP & CFO) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Granted 29,285 options to buy @ $2.87, valued at $84k
08/17/2015 4 Form 4 - Statement of changes in beneficial ownership of securities
07/15/2015 4 Lubner David Charles (SVP and CFO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns: Sold 7,500 shares @ $48.92, valued at $366.9k
Exercised 5,799 options to buy @ $2.03, valued at $11.8k
Exercised 1,701 options to buy @ $7.94, valued at $13.5k
06/16/2015 4 Lubner David Charles (SVP and CFO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns: Sold 10,000 shares @ $41.29, valued at $412.9k
Sold 7,500 shares @ $41.67, valued at $312.5k
Exercised 7,500 options to buy @ $2.03, valued at $15.2k
05/18/2015 4 Lubner David Charles (SVP and CFO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns: Sold 7,684 shares @ $39.28, valued at $301.8k
Sold 7,316 shares @ $39.28, valued at $287.4k
Exercised 7,684 options to buy @ $2.03, valued at $15.6k
Exercised 7,316 options to buy @ $2.03, valued at $14.9k
01/09/2015 4 Lubner David Charles (SVP and CFO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns: Granted 100,000 options to buy @ $39.94, valued at $4M
06/18/2014 4 Lubner David Charles (SVP and CFO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns: Sold 13,530 shares @ $12.51, valued at $169.3k
03/10/2014 4 Lubner David Charles (SVP and CFO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns: Sold 4,510 shares @ $13.65, valued at $61.6k
02/13/2014 4 Lubner David Charles (SVP and CFO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns: Sold 4,506 shares @ $13.92, valued at $62.7k
02/11/2014 4 Lubner David Charles (SVP and CFO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns: Sold 9,928 shares @ $14.22, valued at $141.2k
Exercised 34,482 options to buy @ $0.87, valued at $30k
Exercised 33,295 options to buy @ $2.03, valued at $67.6k
Exercised 20,614 options to buy @ $2.03, valued at $41.8k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy